RINVOQ is a Janus kinase (JAK) inhibitor that works inside your cells to block certain signals that are thought to cause inflammation.
RINVOQ is a prescribed medication utilized for the following conditions:
The safety and effectiveness of RINVOQ in children with juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative colitis, or Crohn’s disease have not been established.
Furthermore, RINVOQ is indicated for:
However, the safety and effectiveness of RINVOQ in children under 12 years of age with atopic dermatitis are currently unknown.
RINVOQ may cause serious side effects, including:
Do not take RINVOQ if you are allergic to upadacitinib or any of the ingredients in RINVOQ. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.